Seizure Control, Tolerability, and Direct Drug Cost of Lamotrigine Versus Carbamazepine in Adults With Focal Epilepsy in a Randomized Open-Label Trial in Bangladesh
Cureus · 03.11.2026
DOI: 10.7759/cureus.119034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 03.11.2026. Verfasst von Mohammad Osman und 9 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Osman, M., Islam, M. A., Abdullah, M. A. A., Urmi, M. I., Akhter, S., Akter, J., Aurpa, N. N., Rupsa, M. S., Ahmed, K. G. U., & Mahmud, R. (2026). Seizure Control, Tolerability, and Direct Drug Cost of Lamotrigine Versus Carbamazepine in Adults With Focal Epilepsy in a Randomized Open-Label Trial in Bangladesh. Cureus. https://doi.org/10.7759/cureus.119034
Vancouver
Osman M, Islam MA, Abdullah MAA, Urmi MI, Akhter S, Akter J, et al. Seizure Control, Tolerability, and Direct Drug Cost of Lamotrigine Versus Carbamazepine in Adults With Focal Epilepsy in a Randomized Open-Label Trial in Bangladesh. Cureus. 2026. doi:10.7759/cureus.119034
BibTeX
@article{Osman2026,
author = {Osman, Mohammad and Islam, Md. Amirul and Abdullah, Md. Ameer Abbas and Urmi, Moushumi Islam and Akhter, Sharmin and Akter, Jahanara and Aurpa, Nishat Nayla and Rupsa, Marjan Siddika and Ahmed, Kazi Gias Uddin and Mahmud, Reaz},
title = {Seizure Control, Tolerability, and Direct Drug Cost of Lamotrigine Versus Carbamazepine in Adults With Focal Epilepsy in a Randomized Open-Label Trial in Bangladesh},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.119034}
}
EUVIMED